Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Legence Corp. Class A Common stock | LGN | 4.49K | $383.02K |
Delek US Holdings, Inc. | DK | 4.67K | $237.38K |
AXT, Inc. | AXTI | 4.78K | $344.25K |
Ouster, Inc. | OUST | 4.79K | $299.66K |
Vera Therapeutics, Inc. | VERA | 4.89K | $209.74K |
Establishment Labs Holdings Inc. | ESTA | 5.09K | $437.12K |
Hut 8 Corp. | HUT | 5.19K | $599.39K |
Alnylam Pharmaceuticals, Inc. | ALNY | 5.2K | $1.57M |
NVE Corporation | NVEC | 5.35K | $558.92K |
Edgewise Therapeutics, Inc. | EWTX | 5.47K | $222.25K |
Lemonade, Inc. | LMND | 5.5K | $357.97K |
Strategy Inc | MSTR | 5.51K | $478.61K |
Oil-Dri Corporation of America | ODC | 5.53K | $565.32K |
Royal Bank of Canada | RY | 5.6K | $1.16M |
CG Oncology Inc. | CGON | 5.64K | $400.86K |
Miami International Holdings, Inc. | MIAX | 5.86K | $217.57K |
Immunovant, Inc. | IMVT | 6.53K | $251.41K |
Upstart Holdings, Inc. | UPST | 6.54K | $231.85K |
Centuri Holdings, Inc. | CTRI | 6.77K | $204.78K |
Travere Therapeutics, Inc. | TVTX | 6.84K | $388.35K |